Menu

Pressure Mounts for EPA’s Scott Pruitt to Quit

Republicans and conservative media outlets are turning on the agency administrator as allegations of ethical misconduct and excessive spending pile up.

Jun 14, 2018
Catherine Offord

WIKIMEDIA, GAGE SKIDMOREScott Pruitt, head of the US Environmental Protection Agency, is under growing pressure to resign amid snowballing allegations of ethical misconduct. The latest criticisms follow a report by The Washington Post earlier this week that exposed Pruitt’s efforts to use his position to line up job opportunities for his wife.

Senator James Inhofe (R-OK.), once Pruitt’s political ally, was particularly critical in a conversation with conservative radio host Laura Ingraham on Wednesday (June 13), Vox reports. Inhofe noted that the EPA’s deputy administrator, Andrew Wheeler, was well qualified to take over the top post. Speaking of Pruitt's role, “I think something needs to happen to change that, and one of those alternatives is for [Pruitt] to leave that job,” he said. Ingraham herself has called on Pruitt to resign.

According to Reuters, Inhofe and several other Republican senators yesterday called for Pruitt to testify before Congress. Various government offices are undertaking a dozen investigations into the administrator’s behavior.

Also on Wednesday, conservative magazine National Review published an editorial entitled “Scott Pruitt Should Go.” In the article, the editors write that “we are now at a point where a good week for Pruitt sees only one report of behavior that is bizarre or venal.” They also noted Wheeler’s ability to take over. “Pruitt is replaceable. And he should be replaced,” they write.

The pressure on Pruitt has been building for some time. Already by the middle of April, four House Republicans had called on Pruitt to leave the post after reports surfaced about the administrator’s use of taxpayer money to fund first-class travel and to build a $43,000 soundproof booth in his office. “Yes EPA Administrator Scott Pruitt should resign,” tweeted Representative Frank LoBiondo (R-NJ) on April 22. “Wrong fit from start for agency dedicated to protecting our environment.”

See “Scott Pruitt’s Questionable Practices Exposed

Not everyone has been critical. Last week (June 6), President Donald Trump told an audience at the Federal Emergency Management Agency headquarters that “EPA is doing really, really well,” Reuters reports. Addressing Pruitt directly, he added, “Somebody has to say that about you a little bit, you know that, Scott.”

Combined with a $3.5-million bill for a round-the-clock security detail, Pruitt’s spending has now cost the taxpayer more than $3,750,000, according to a tally kept by The Washington Post. The EPA has yet to comment on the matter, according to the Post.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.